
09/10/2025
FDA approves Libtayo as immunotherapy for adjuvant treatment of CSCC
Read more here: https://bit.ly/4hmQDqF
Subscribe to our weekly newsletter for the latest news delivered to your inbox: https://bit.ly/47sT3kl